|

 |
Dr John Earl
PhD
|
 |
Danny Sampson
BSc,
MSc, FAACB |
 |
Dr Dilo Pillai
PhD |
 |
Trudi Jones
|
 |
Dr Irina Piatkov
PhD
|
 |
Jill Buchmann
BSc, Dip Ed, MBA |
 |
Chris Salonikas
BAppSc,
MAppSc |

PM Separations

Australian Scientific
Enterprise

RCPA Quality Assurance
Programs Pty Limited

BIO-RAD

VARIAN

DIONEX

Waters

Astral Scientific

Shimadzu Scientific

CHROMSYSTEMS

Stanton Scientific

Applied Biosystems
Analytical
Technologies

MERCK

|
Australasian Association of Clinical Biochemists
"Coming Together
to Separate"
Dr CS Ho

Biography
Dr Chung Shun HO
obtained his BSc (Hon) degree in Biochemistry and MSc degree in Clinical
Biochemistry from the University of Regina, Saskatchewan, Canada, and
completed his PhD degree in Chemical Pathology at the Chinese University of
Hong Kong. He was appointed Scientific Officer (Medical) in the Department
of Chemical Pathology at the Prince of Wales Hospital in 1983 and has also
held an honorary academic post at the Chinese University of Hong Kong since
1985. Dr Ho has been an active clinical scientist in Hong Kong serving as
President of the Hong Kong Society of Clinical Chemistry; and founding
council member of the Hong Kong Society of Mass Spectrometry.
In 1995, Dr Ho was appointed as the in-charge scientist of the Biomedical
Mass Spectrometry Unit at the Prince of Wales Hospital. He gained extensive
experience in using gas chromatography mass spectrometry for assessment of
in vivo oxidative stress, liquid chromatography tandem mass spectrometry
system for protein glycoforms of cancer markers, in-born errors of
metabolism & drugs of abuse; and isotope-ratio mass spectrometry for total
energy expenditure. In 2002, Dr Ho established the first routine laboratory
in Hong Kong using liquid chromatography electrospray ionization tandem mass
spectrometry at the New Territories East Cluster Mass Spectrometry
Laboratory located at the North District Hospital. This laboratory now
provides routine assay service for whole blood immunosuppressants (Cyclosporin
A, Everolimus, Sirolimus and Tacrolimus) and serum 17-hydroxyprogesterone
measurements for the Cluster and many other hospitals in Hong Kong.
Quantitation of other steroids, such as cortisol, cortisone,
6b-hydroxycortisol testosterone, and androstenedione in serum and urine
samples is also being developed. Recently, he is also involved in the use of
liquid chromatography time of flight mass spectrometry for general
toxicology screening in the routine clinical laboratory.
|
Any comments
refering to the webpage please contact
Chris Salonikas
(WebMaster)
SEALS Clinical Chemistry
POWH Ph (02) 9382 9067 Fax 9382 9099
chrissalon@ozemail.com.au |
|